Evidence map›Paper›PMID 39981059›Full record

ArticleMethodsX2025

QuantumNet: An enhanced diabetic retinopathy detection model using classical deep learning-quantum transfer learning.

Manish Bali, Ved Prakash Mishra, Anuradha Yenkikar, Diptee Chikmurge

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manish BaliSchool of Engineering, Amity University Dubai Campus, Dubai, 25314, UAE.
Ved Prakash MishraSchool of Engineering, Amity University Dubai Campus, Dubai, 25314, UAE.
Anuradha YenkikarSchool of Engineering, Amity University Dubai Campus, Dubai, 25314, UAE.
Diptee ChikmurgeSchool of Computer Engineering, MIT Academy of Engineering, Alandi (D), Pune, 412105, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic Retinopathy (DR), a diabetes-related eye condition, damages retinal blood vessels and can lead to vision loss if undetected early. Precise diagnosis is challenging due to subtle, varied symptoms. While classical deep learning (DL) models like CNNs and ResNet's are widely used, they face resource and accuracy limitations. Quantum computing, leveraging quantum mechanics, offers revolutionary potential for faster problem-solving across fields like cryptography, optimization, and medicine. This research introduces QuantumNet, a hybrid model combining classical DL and quantum transfer learning to enhance DR detection. QuantumNet demonstrates high accuracy and resource efficiency, providing a transformative solution for DR detection and broader medical imaging applications. The method is as follows:•Evaluate three classical deep learning models-CNN, ResNet50, and MobileNetV2-using the APTOS 2019 blindness detection dataset on Kaggle to identify the best-performing model for integration.•QuantumNet combines the best-performing classical DL model for feature extraction with a variational quantum classifier, leveraging quantum transfer learning for enhanced diagnostics, validated statistically and on Google Cirq using standard metrics.•QuantumNet achieves 94.11 % accuracy, surpassing classical DL models and prior research by 11.93 percentage points, demonstrating its potential for accurate, efficient DR detection and broader medical imaging applications.

Indexed as

APTOS 2019Convolution neural networkDiabetic retinopathyHybrid Deep Learning-Quantum Transfer Learning for Diabetic Retinopathy DetectionMobileNetQuantum transfer learningResNet

Identifiers

PMID39981059
PMCPMC11840206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.